AstraZeneca Study Lead Tells South Africa Not to Be Reckless

The lead researcher of the South African trial of AstraZeneca Plc's coronavirus vaccine urged authorities in the country to continue using the shot to cut death and hospitalization rates and the chance of further virus mutations. The latest Covid updates.

from Google Alert - Business https://ift.tt/3b5nNcD
The lead researcher of the South African trial of AstraZeneca Plc's coronavirus vaccine urged authorities in the country to continue using the shot to cut death and hospitalization rates and the chance of further virus mutations. The latest Covid updates. https://ift.tt/eA8V8J

Comments

Popular posts from this blog

Jobless Rate Drops

Electrolytic Fixed Power Capacitors Market Competitive intelligence & regional outlook 2020

USU project among finalists for $3 million solar energy tech prize